{
    "2021-11-18": [
        [
            {
                "time": "2023-11-01",
                "original_text": "AbbVie's (ABBV) Skyrizi Gets Nod for Psoriatic Arthritis in EU",
                "features": {
                    "keywords": [
                        "Skyrizi",
                        "Nod",
                        "Psoriatic Arthritis",
                        "EU"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "Pharma Stock Roundup: JNJ to Spin Off Consumer Unit, PFE Eyes EUA for COVID Pill",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Spin Off",
                        "Consumer Unit",
                        "PFE",
                        "EUA",
                        "COVID Pill"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "New Literature Review Highlights Economic Benefits Associated with Achieving Rheumatoid Arthritis Remission",
                "features": {
                    "keywords": [
                        "Literature Review",
                        "Economic Benefits",
                        "Rheumatoid Arthritis",
                        "Remission"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "10 Dividend Stocks to Buy According to Greg Eisner’s Engineers Gate Manager",
                "features": {
                    "keywords": [
                        "Dividend Stocks",
                        "Greg Eisner",
                        "Engineers Gate Manager"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "Berkshire Exited Merck Before COVID Pill Boost; Trimmed Holdings In AbbVie, Bristol Myers In Q3",
                "features": {
                    "keywords": [
                        "Berkshire",
                        "Merck",
                        "COVID Pill",
                        "Trimmed Holdings",
                        "AbbVie",
                        "Bristol Myers",
                        "Q3"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-01",
                "original_text": "AbbVie Announces First Provincial Reimbursement for VENCLEXTA® (venetoclax) with Obinutuzumab for Patients with Previously Untreated Chronic Lymphocytic Leukemia in Quebec",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "VENCLEXTA",
                        "Reimbursement",
                        "Chronic Lymphocytic Leukemia",
                        "Quebec"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}